Amphastar Pharmaceuticals, Inc. (AMPH)
21.51
-0.09
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
21.51
0.00 (0.00%)
After-Hours: 20:00
Amphastar Pharmaceuticals Net Income (Quarterly) : 30.35M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 30.35M |
| March 31, 2026 | 6.42M |
| December 31, 2025 | 24.43M |
| September 30, 2025 | 17.35M |
| June 30, 2025 | 31.03M |
| March 31, 2025 | 25.28M |
| December 31, 2024 | 37.96M |
| September 30, 2024 | 40.43M |
| June 30, 2024 | 37.95M |
| March 31, 2024 | 43.18M |
| December 31, 2023 | 36.17M |
| September 30, 2023 | 49.22M |
| June 30, 2023 | 26.12M |
| March 31, 2023 | 26.03M |
| December 31, 2022 | 33.91M |
| September 30, 2022 | 15.87M |
| June 30, 2022 | 17.35M |
| March 31, 2022 | 24.25M |
| December 31, 2021 | 19.76M |
| September 30, 2021 | 30.96M |
| June 30, 2021 | 8.622M |
| March 31, 2021 | 3.959M |
| December 31, 2020 | -5.792M |
| September 30, 2020 | 4.793M |
| June 30, 2020 | -1.429M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.525M |
| December 31, 2019 | 0.755M |
| September 30, 2019 | 0.984M |
| June 30, 2019 | 46.92M |
| March 31, 2019 | -2.154M |
| December 31, 2018 | 1.718M |
| September 30, 2018 | 1.616M |
| June 30, 2018 | -2.853M |
| March 31, 2018 | -7.141M |
| December 31, 2017 | 0.787M |
| September 30, 2017 | 0.175M |
| June 30, 2017 | 1.972M |
| March 31, 2017 | 0.893M |
| December 31, 2016 | -2.742M |
| September 30, 2016 | 3.89M |
| June 30, 2016 | 6.895M |
| March 31, 2016 | 2.489M |
| December 31, 2015 | 7.533M |
| September 30, 2015 | -3.008M |
| June 30, 2015 | -6.647M |
| March 31, 2015 | -0.665M |
| December 31, 2014 | -2.521M |
| September 30, 2014 | -5.379M |
| June 30, 2014 | -1.18M |
| March 31, 2014 | -1.619M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | -58.37M |
| Liquidia Corp. | 74.72M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 183.90M |
| Total Expenses (Quarterly) | 153.56M |
| EPS Diluted (Quarterly) | 0.6862 |
| Enterprise Value | 1.314B |
| Gross Profit Margin (Quarterly) | 48.73% |
| Profit Margin (Quarterly) | 16.50% |
| Earnings Yield | 7.93% |
| Operating Earnings Yield | 11.46% |
| Normalized Earnings Yield | 7.024 |